Allergy Asthma Respir Dis.
2017 Nov;5(6):305-306. 10.4168/aard.2017.5.6.305.
Safety of ultrarush immunotherapy
- Affiliations
-
- 1Department of Pediatrics, Inha University School of Medicine, Incheon, Korea. dhyunlim@inha.ac.kr
- KMID: 2396669
- DOI: http://doi.org/10.4168/aard.2017.5.6.305
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
- Safety of ultrarush allergen subcutaneous immunotherapy in children with allergic disease
- Safety and efficacy of the ultra-rush immunotherapy with extracts of Dermatophagoides pteronyssinus in children
- Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
- Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
